AIM ImmunoTech IncAIM
Price$0.17

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $95K-44.1% YoYTTM through 30 Jun 2026
Net Income -$14.3MTTM through 30 Jun 2026
Free Cash Flow -$14.4MTTM through 30 Jun 2026

Margins

Current
Operating Margin-12,471.0%
Net Margin-15,021.1%

Returns

142.5%ROE
-162.5%ROA

Balance Sheet Health

Debt / Equity-0.43x
Current Ratio0.50x
Net Debt$1.2M
Cash & Equivalents$9.9M

Quality Metrics

Altman Z-Score-50.57
Piotroski F-Score3 / 9
FCF Margin-15,149.5%
Earnings-Beat Rate50.0%

Multi-Year Trend

Revenue
'14'17'18'22'23'24'25
FY2025: $88K
Diluted EPS-$0.70TTM
'22'23'24'25
FY2025: $-8.62

Dividend

No dividend

Capital Allocation

Capex Intensity18.9%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.